help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0082
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rønn, S. G.
Right arrow Articles by Billestrup, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rønn, S. G.
Right arrow Articles by Billestrup, N.
Molecular Endocrinology 16 (9): 2124-2134
Copyright © 2002 by The Endocrine Society

The Effect of Suppressor of Cytokine Signaling 3 on GH Signaling in ß-Cells

Sif G. Rønn, Johnny A. Hansen, Karen Lindberg, Allan E. Karlsen and Nils Billestrup

Steno Diabetes Center (S.G.R., A.E.K., N.B.), DK-2820 Gentofte, Denmark; and Signal Transduction (S.G.R., J.A.H., K.L., N.B.), Novo Nordisk A/S, DK-2880 Bagsværd, Denmark

Address all correspondence and requests for reprints to: Nils Billestrup, Steno Diabetes Center, Niels Steensensvej 6, DK-2820 Gentofte, Denmark. E-mail: nbil{at}novonordisk.com.

GH is an important regulator of cell growth and metabolism. In the pancreas, GH stimulates mitogenesis as well as insulin production in ß-cells. The cellular effects of GH are exerted mainly through activation of the Janus kinase-signal transducer and activator of transcription (STAT) pathway. Recently it has been found that suppressors of cytokine signaling (SOCS) proteins are able to inhibit GH-induced signal transduction. In the present study, the role of SOCS-3 in GH signaling was investigated in the pancreatic ß-cell lines RIN-5AH and INS-1 by means of inducible expression systems. Via stable transfection of the ß-cell lines with plasmids expressing SOCS-3 under the control of an inducible promoter, a time- and dose-dependent expression of SOCS-3 in the cells was obtained. EMSA showed that SOCS-3 is able to inhibit GH-induced DNA binding of both STAT3 and STAT5 in RIN-5AH cells. Furthermore, using Northern blot analysis it was shown that SOCS-3 can completely inhibit GH-induced insulin production in these cells. Finally, 5-bromodeoxyuridine incorporation followed by fluorescence-activated cell sorting analysis showed that SOCS-3 inhibits GH-induced proliferation of INS-1 cells. These findings support the hypothesis that SOCS-3 is a major regulator of GH signaling in insulin-producing cells.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. F. Tonnesen, L. G. Grunnet, J. Friberg, A. K. Cardozo, N. Billestrup, D. L. Eizirik, J. Storling, and T. Mandrup-Poulsen
Inhibition of Nuclear Factor-{kappa}B or Bax Prevents Endoplasmic Reticulum Stress- But Not Nitric Oxide-Mediated Apoptosis in INS-1E Cells
Endocrinology, September 1, 2009; 150(9): 4094 - 4103.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G. Kenth, J. A M. Mergelas, and C. G. Goodyer
Developmental changes in the human GH receptor and its signal transduction pathways
J. Endocrinol., July 1, 2008; 198(1): 71 - 82.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen
Diabetes and Suppressors of Cytokine Signaling Proteins
Diabetes, February 1, 2007; 56(2): 541 - 548.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Frobose, S. Groth Ronn, P. E. Heding, H. Mendoza, P. Cohen, T. Mandrup-Poulsen, and N. Billestrup
Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6/TAK1 Complex
Mol. Endocrinol., July 1, 2006; 20(7): 1587 - 1596.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K Lindberg, S G Ronn, D Tornehave, H Richter, J A Hansen, J Romer, M Jackerott, and N Billestrup
Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3
J. Mol. Endocrinol., October 1, 2005; 35(2): 231 - 243.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Emanuelli, M. Glondu, C. Filloux, P. Peraldi, and E. Van Obberghen
The Potential Role of SOCS-3 in the Interleukin-1{beta}-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells
Diabetes, December 1, 2004; 53(suppl_3): S97 - S103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Sitko, C. I. Guevara, and N. A. Cacalano
Tyrosine-phosphorylated SOCS3 Interacts with the Nck and Crk-L Adapter Proteins and Regulates Nck Activation
J. Biol. Chem., September 3, 2004; 279(36): 37662 - 37669.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson
Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans
Endocrinology, September 1, 2004; 145(9): 4162 - 4175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society